en · de · es · pt
cjc-1295-notes.peptides3081.com › News › Compound Identity And Development History — Complete Guide

Compound Identity And Development History — Complete Guide

By Editorial Desk · published 2026-02-12 · last reviewed 2026-03-09 · News

The short version of lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-03-09. Anything still debated is marked as such rather than presented as settled.

Compound Identity and Development History

Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.

CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.

The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.

Persistence, Stability and Measurement

Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.

Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.

The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.

Cjc-1295 at a glance

PropertyValueNotes
Molecular formulaC152H252N44O42Cited for the form without the drug affinity complex
Molecular weightAbout 3368 DaReported value for modified GRF(1-29)
AppearanceWhite to off-white powderLyophilised solid as usually supplied
SolubilitySoluble in water and polar solventsClarity depends on purity and salt content
Typical storage-20 C or below, dryProtect from light and repeated warming cycles

Background and Molecular Features

CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.

Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.

Related pages on this site

Handling Storage and Quality Control

Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.

Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.

Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.

CJC-1295 Background and Mechanism

CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.

The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.

Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.

Notes from published material

=== Change in anti-terrorist policy and "peripheral" nationalisms === The PP government developed an anti-terrorist policy based on an idea that no democratic government had defended until then: that only police measures could put an end to ETA. Thus, the only possible "dialogue" with ETA was the handing over of weapons. The government reaped a resounding first success with the release in early July 1997 of José Ortega Lara, a prison officer and PP militant who had been held hostage by ETA for 532 days. But a few days later, on July 10, an event took place that would open a new stage in the history of the "Basque conflict". That day ETA kidnapped Miguel Ángel Blanco, a young PP councilman from the Biscayan town of Ermua, which provoked the largest social mobilization against terrorism in living memory. But after the deadline given for the prisoners of the organization to be transferred to prisons in the Basque Country, ETA assassinated Miguel Ángel Blanco, which increased even more the rejection of ETA and its "political arm", Herri Batasuna. The press began to use the term "spirit of Ermua" to explain that immense anti-terrorist social mobilization. In March 1998, the lehendakari José Antonio Ardanza announced a "Pacification Plan" in which, based on the Ajuria Enea Pact of 1988, he proposed that after achieving the cessation of ETA's violence, a dialogue should be opened between all the Basque political forces, the result of which should be accepted by the central government and the rest of the institutions of the State.

== Radiology == CT scan (B*2****) magnetic resonance imaging (MRI) (B*3****) nuclear medicine (C******) positron-emission tomography (PET) projectional radiography (B*0****) ultrasonography (B*4****) Alternative list formatting:

== Humanities == In philosophy, the end result of a dialectic as in thesis, antithesis, synthesis A cognitive skill in Benjamin Bloom's Taxonomy of Educational Objectives In philosophy and cognitive science, a foundational a priori process In linguistics, a scale denoting the average ratio of morphemes to words; see synthetic language In legal theory, the process of condensing and combining large quantities of information

== Signs and symptoms == Atherosclerosis is typically asymptomatic for decades because the arteries enlarge at all plaque locations; thus, there is no effect on blood flow. Even most plaque ruptures do not produce symptoms until enough narrowing or closure of an artery, due to clots, occurs. Signs and symptoms only happen after severe narrowing or closure impedes blood flow to different organs enough to induce symptoms. Most of the time, patients realize that they have the disease only when they experience other cardiovascular disorders such as stroke or heart attack. These symptoms, however, still vary depending on which artery or organ is affected. Early atherosclerotic processes likely begin in childhood. Fibrous and gelatinous lesions have been observed in the coronary arteries of children. Fatty streaks have been observed in the coronary arteries of juveniles. While coronary artery disease is more prevalent in men than women, atherosclerosis of the cerebral arteries and strokes equally affect both sexes. Marked narrowing in the coronary arteries, which are responsible for bringing oxygenated blood to the heart, can produce symptoms such as chest pain of angina and shortness of breath, sweating, nausea, dizziness or lightheadedness, breathlessness or palpitations. Abnormal heart rhythms called arrhythmias—the heart beating either too slowly or too quickly—are another consequence of ischemia. Carotid arteries supply blood to the brain and neck.

Sources: en.wikipedia.org

Further detail

== Safety == Due to its radioactivity, curium and its compounds must be handled in appropriate labs under special arrangements. While curium itself mostly emits α-particles which are absorbed by thin layers of common materials, some of its decay products emit significant fractions of beta and gamma rays, which require a more elaborate protection. If consumed, curium is excreted within a few days and only 0.05% is absorbed in the blood. From there, ~45% goes to the liver, 45% to the bones, and the remaining 10% is excreted. In bone, curium accumulates on the inside of the interfaces to the bone marrow and does not significantly redistribute with time; its radiation destroys bone marrow and thus stops red blood cell creation. The biological half-life of curium is about 20 years in the liver and 50 years in the bones. Curium is absorbed in the body much more strongly via inhalation, and the allowed total dose of 244Cm in soluble form is 0.3 μCi. Intravenous injection of 242Cm- and 244Cm-containing solutions to rats increased the incidence of bone tumor, and inhalation promoted lung and liver cancer. Curium isotopes are inevitably present in spent nuclear fuel (about 20 g/tonne). The isotopes 245Cm–248Cm have decay times of thousands of years and must be removed to neutralize the fuel for disposal. Such a procedure involves several steps, where curium is first separated and then converted by neutron bombardment in special reactors to short-lived nuclides. This procedure, nuclear transmutation, while well documented for other elements, is still being developed for curium.

== Occurrence == GBL has been found in extracts from samples of unadulterated wines. This finding indicates that GBL is a naturally occurring component in some wines and may be present in similar products. The concentration detected was approximately 5 μg/mL and was easily observed using a simple extraction technique followed by GC/MS analysis. GBL can be found in cheese flavorings but typically results in a content of 0.0002% GBL in the final foodstuff.

As JD Vance and Marco Rubio met the Danish and Greenlandic foreign ministers Lars Løkke Rasmussen and Vivian Motzfeldt, the White House posted a meme on Twitter with the question: "Which way, Greenland man?" with imagery implying a choice between the United States and an ominous-looking China and Russia. Heidi Beirich of the Global Project Against Hate and Extremism described the meme as reflecting a key concept in neo-Nazi and white supremacist subculture, explaining that "Western man is code for white man, and one of the most popular racist books in these subcultures is Which Way Western Man, which has been featured in a Department of Homeland Security post celebrating manifest destiny." Trump has engaged in online trolling, posting an altered image that features the US flag covering Canada, Greenland, and Venezuela and an AI image of himself planting a US flag in Greenland, marked as "US territory" and "EST. 2026." Paul Buvarp, a researcher on disinformation and propaganda at the Norwegian Defence Research Establishment, described Trump's claims about imminent Chinese and Russian threats to Greenland as detached from observable reality and emblematic of information manipulation rather than genuine security analysis. Buvarp argued that the rhetoric functions as propaganda by deliberately creating uncertainty, anxiety, and confusion. On 29 January 2026, German broadcaster Norddeutscher Rundfunk was fined by Greenlandic police after comic artist Maxi Schafroth attempted to raise the US flag near a cultural centre in Nuuk as part of a stunt.

Sources: en.wikipedia.org

Background from the literature

The Cuban activist and historian Emilio Roig de Leuchsenring wrote of Freemasonry in Cuba:"To fully express what Freemasonry represents for us in a few words, suffice to say that, without mentioning it once, twice and perhaps a thousand times, one cannot write the history of Cuban culture or Cuba's struggle for freedom."

=== Adulthood === Human vocal cords are paired structures located in the larynx, just above the trachea, which vibrate and are brought in contact during phonation. The human vocal cords are roughly 12–24 mm in length, and 3–5 mm thick. Histologically, the human vocal cords are a laminated structure composed of five different layers. The vocalis muscle, main body of the vocal cords, is covered by the mucosa, which consists of the epithelium and the lamina propria. The latter is a pliable layer of connective tissue subdivided into three layers: the superficial layer (SL), the intermediate layer (IL), and the deep layer (DL). Layer distinction is either made looking at differential in cell content or extracellular matrix (extracellular matrix) content. The most common way being to look at the extracellular matrix content. The SLP has fewer elastic and collagenous fibers than the two other layers, and thus is looser and more pliable. The ILP is mostly composed of elastic fibers, while the DLP has fewer elastic fibers, and more collagenous fibers. In those two layers, which form what is known as the vocalis ligament, the elastic and collagenous fibers are densely packed as bundles that run almost parallel to the edge of the vocal fold. There is a steady increase in the elastin content of the lamina propria as humans age (elastin is a yellow scleroprotein, the essential constituent of the elastic connective tissue) resulting in a decrease in the ability of the lamina propria to expand caused by cross-branching of the elastin fibers.

For the use of hormone antagonists in cancer, see hormonal therapy (oncology) A hormone antagonist is a molecule, produced either synthetically or endogenously, that binds to a specific hormone receptor to block the effect or synthesis of that hormone. There are many types of hormone antagonists, such as gonadotropin-releasing hormone (GnRH) antagonists, estrogen antagonists, and androgen antagonists. Organisms may use hormone antagonists to modify the action of their hormone receptors. For example, ghrelin is a hormone that stimulates appetite and growth hormone release by activating the growth hormone secretagogue receptor (GHSR). LEAP2 was found to be a peptide hormone synthesized by the liver and small intestine that blocks the GHSR activation by ghrelin, thereby reducing appetite. Synthetically produced hormone antagonists can also be used as anticancer treatments for hormone-sensitive cancers like breast cancer and prostate cancer.

Juvéderm (), an injectable filler (injectable facial filler), is used by cosmetic, dermatological, and plastic surgeons to soften deep folds and reduce wrinkles in the faces of patients. The substance is largely hyaluronic acid, a substance normally found in the skin, muscles, and tendons of mammals. Approved in June 2006 by the U.S. Food and Drug Administration, Juvéderm’s prime use is removing nasolabial folds, or “smile lines,” creases of skin which run from the corners of the nose to the corners of the mouth. It is also used as a lip augmentation agent, and to fill in hollow places and scars on the face. However, all hyaluronic acid facial filler products are eventually absorbed by the body, usually within six to nine months, requiring the patient to undergo repeat injections to maintain the younger look. Juvéderm is also used by physicians to plump lips, which also lose fat and internal shape with normal aging.

Sources: en.wikipedia.org

Frequently asked questions

What is CJC-1295?

It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.

Is CJC-1295 an approved medicine?

No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.

How does it differ from sermorelin?

Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.

What is the difference between the forms with and without a drug affinity complex?

The version carrying the affinity complex bears a maleimide group that binds serum albumin, which extends its circulation time to several days. The version without it lacks this group and clears within roughly half an hour. The two are chemically related but behave very differently once in the body.

Network